~Having an*l, v*ginal, or *ral s*x without a condom;
~Having multiple s*x partners;
~Having anonymous s*x partners;
~Having s*x while under the influence of drugs or alcohol can lower inhibitions and result in greater s*xual risk-taking.
You can prevent these by:
~Having <em>safe </em>s*x
~Not doing drugs
I think A , please correct me if i’m wrong
To depict the recurrence of weight ulcer hazard appraisal in pediatric patients and weight ulcer avoidance intercession utilize by and large and by healing center unit sort, a clear auxiliary examination was performed of information submitted to the National Database for Nursing Quality Indicators (NDNQI) for at slightest 3 of the 4 quarters in 2012.
Significant information on weight ulcer hazard from 271 clinics over the Joined together States extricated from the NDNQI database included understanding skin and weight ulcer hazard evaluation on confirmation, time since the final weight ulcer hazard appraisal, strategy utilized to survey weight ulcer hazard, and chance status.
Extricated information on weight ulcer anticipation included skin evaluation, pressure-redistribution surface utilize, schedule repositioning, wholesome bolster, and dampness administration. These information were organized by unit sort and consolidated with information on clinic characteristics for the investigation.
The frequency of prevention intervention use among those at risk ranged from 99.2% for skin assessment to 70.7% for redistribution surface use.
To learn more about pressure ulcers from the given link
brainly.com/question/13543322
#SPJ4
Answer:
Drug-drug interactions (DDIs) are one of the commonest causes of medication error in developed countries, particularly in the elderly due to poly-therapy, with a prevalence of 20-40%. In particular, poly-therapy increases the complexity of therapeutic management and thereby the risk of clinically important DDIs, which can both induce the development of adverse drug reactions or reduce the clinical efficacy. DDIs can be classify into two main groups: pharmacokinetic and pharmacodynamic. In this review, using Medline, PubMed, Embase, Cochrane library and Reference lists we searched articles published until June 30 2012, and we described the mechanism of pharmacokinetic DDIs focusing the interest on their clinical implications.
Keywords: Absorption, adverse drug reaction, distribution, drug-drug interactions, excretion, metabolism, poly-therapy
